Prothena Corp Public (PRTA) Operating Leases (2019 - 2026)
Prothena Corp Public (PRTA) recorded quarterly Operating Leases of $7.7 million in Q1 2026, up 39.49% quarter-over-quarter from $5.5 million in Q4 2025, and up 1.04% on a YoY basis from $7.6 million in Q1 2025.
Prothena Corp Public (PRTA) Operating Leases (2019 - 2026) Analysis & Trends
Prothena Corp Public's Operating Leases history runs 8 years deep, the most recent figure standing at $7.7 million for Q1 2026.
- In Q1 2026, Operating Leases rose 1.04% year-over-year to $7.7 million; the TTM figure through Mar 2026 stood at $7.7 million (up 1.04% YoY), while the FY2025 annual figure was $5.5 million, down 33.35% from the prior year.
- Operating Leases was $7.7 million for Q1 2026 at Prothena Corp Public, up from $5.5 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $12.1 million in Q2 2024 to a low of $1.6 million in Q3 2022.
- Historically, Operating Leases has averaged $7.4 million across 5 years, with a median of $7.6 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Operating Leases tumbled 79.18% in 2022, then jumped 551.0% in 2023.
- A 5-year view of Operating Leases shows it stood at $1.6 million in 2022, then soared by 550.15% to $10.7 million in 2023, then slipped by 23.21% to $8.2 million in 2024, then plunged by 33.35% to $5.5 million in 2025, then surged by 39.49% to $7.7 million in 2026.
- The last three Operating Leases figures came in at $7.7 million (Q1 2026), $5.5 million (Q4 2025), and $6.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.65 Mn |
| Dec 31, 2025 | 5.49 Mn |
| Sep 30, 2025 | 6.20 Mn |
| Jun 30, 2025 | 6.93 Mn |
| Mar 31, 2025 | 7.58 Mn |
| Dec 31, 2024 | 8.23 Mn |
| Sep 30, 2024 | 8.88 Mn |
| Jun 30, 2024 | 12.12 Mn |
| Mar 31, 2024 | 10.12 Mn |
| Dec 31, 2023 | 10.72 Mn |
| Sep 30, 2023 | 10.74 Mn |
| Jun 30, 2023 | 3.45 Mn |
| Mar 31, 2023 | 4.89 Mn |
| Sep 30, 2022 | 1.65 Mn |
| Jun 30, 2022 | 3.28 Mn |
| Mar 31, 2022 | 10.88 Mn |
| Dec 31, 2021 | 6.39 Mn |
| Sep 30, 2021 | 7.92 Mn |
| Jun 30, 2021 | 9.43 Mn |
| Mar 31, 2021 | 10.88 Mn |